X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38447) 38447
Newsletter (240) 240
Newspaper Article (171) 171
Magazine Article (66) 66
Book / eBook (43) 43
Book Chapter (25) 25
Conference Proceeding (22) 22
Dissertation (12) 12
Publication (4) 4
Web Resource (4) 4
Book Review (2) 2
Transcript (2) 2
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35177) 35177
male (20247) 20247
female (19151) 19151
middle aged (17071) 17071
stomach neoplasms - pathology (15836) 15836
aged (15426) 15426
oncology (12601) 12601
stomach cancer (11400) 11400
stomach neoplasms - drug therapy (11292) 11292
adult (11060) 11060
cancer (10913) 10913
gastric cancer (9972) 9972
stomach neoplasms - surgery (8532) 8532
surgery (6993) 6993
prognosis (6882) 6882
chemotherapy (5495) 5495
aged, 80 and over (5089) 5089
stomach neoplasms - therapy (4986) 4986
antineoplastic combined chemotherapy protocols - therapeutic use (4970) 4970
gastroenterology & hepatology (4905) 4905
stomach neoplasms - mortality (4870) 4870
metastasis (4736) 4736
treatment outcome (4655) 4655
neoplasm staging (4632) 4632
stomach neoplasms - genetics (4608) 4608
stomach neoplasms - metabolism (4376) 4376
carcinoma (4366) 4366
gastrectomy (4365) 4365
cell line, tumor (4114) 4114
animals (4086) 4086
medicine & public health (4040) 4040
tumors (3994) 3994
retrospective studies (3767) 3767
research (3550) 3550
expression (3519) 3519
stomach (3407) 3407
analysis (3351) 3351
care and treatment (3340) 3340
stomach neoplasms - diagnosis (3184) 3184
adenocarcinoma (3177) 3177
adenocarcinoma - pathology (3113) 3113
survival rate (3065) 3065
apoptosis (2963) 2963
survival (2910) 2910
health aspects (2816) 2816
combined modality therapy (2725) 2725
mice (2711) 2711
follow-up studies (2655) 2655
risk factors (2654) 2654
adenocarcinoma - drug therapy (2551) 2551
medical prognosis (2550) 2550
lymphatic metastasis (2529) 2529
immunohistochemistry (2450) 2450
cancer therapies (2380) 2380
gene expression (2347) 2347
gastroenterology (2307) 2307
fluorouracil - administration & dosage (2285) 2285
adenocarcinoma - surgery (2194) 2194
proteins (2174) 2174
pathology (2131) 2131
cisplatin - administration & dosage (2130) 2130
helicobacter pylori (2107) 2107
therapy (2095) 2095
survival analysis (2080) 2080
antineoplastic agents - therapeutic use (2047) 2047
patients (2038) 2038
gene expression regulation, neoplastic (1952) 1952
development and progression (1922) 1922
diagnosis (1896) 1896
genetic aspects (1858) 1858
stomach neoplasms - complications (1850) 1850
surgical oncology (1832) 1832
time factors (1811) 1811
studies (1775) 1775
chemotherapy, adjuvant (1724) 1724
mortality (1658) 1658
cisplatin (1656) 1656
stomach neoplasms (1652) 1652
cancer research (1649) 1649
medicine (1639) 1639
drug combinations (1592) 1592
oncology, experimental (1578) 1578
mice, nude (1573) 1573
research article (1563) 1563
neoplasm invasiveness (1550) 1550
cell proliferation (1526) 1526
adenocarcinoma - mortality (1473) 1473
tegafur - administration & dosage (1469) 1469
disease-free survival (1461) 1461
drug administration schedule (1454) 1454
prospective studies (1426) 1426
radiotherapy (1409) 1409
breast-cancer (1403) 1403
neoplasm metastasis (1376) 1376
neoplasms. tumors. oncology. including cancer and carcinogens (1358) 1358
breast cancer (1357) 1357
stomach neoplasms - epidemiology (1340) 1340
gastrectomy - methods (1324) 1324
liver neoplasms - secondary (1322) 1322
stomach neoplasms - microbiology (1321) 1321
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (22) 22
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Online Resources - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Holland Stacks (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (33547) 33547
Japanese (3956) 3956
German (886) 886
Chinese (766) 766
Russian (683) 683
French (423) 423
Italian (255) 255
Spanish (227) 227
Polish (87) 87
Korean (85) 85
Hungarian (52) 52
Portuguese (42) 42
Czech (34) 34
Romanian (28) 28
Dutch (25) 25
Danish (23) 23
Croatian (17) 17
Swedish (13) 13
Serbian (12) 12
Ukrainian (12) 12
Bulgarian (11) 11
Norwegian (10) 10
Turkish (6) 6
Finnish (5) 5
Hebrew (4) 4
Arabic (2) 2
Lithuanian (2) 2
Persian (2) 2
Slovak (2) 2
Afrikaans (1) 1
Greek (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 1, pp. 173 - 177
Multiple primary malignancy is defined as two or more malignancies detected in an individual person. In particular, synchronous quintuple primary malignancy is... 
Colon neoplasm | Small bowel neoplasm | Synchronous quintuple primary cancer | Stomach neoplasm | PRIMARY CANCERS | NEOPLASMS | KIDNEY | GASTROENTEROLOGY & HEPATOLOGY | Rectal Neoplasms - diagnosis | Ileostomy | Colonic Neoplasms - genetics | Jejunal Neoplasms - genetics | Microsatellite Instability | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Colonic Neoplasms - diagnosis | Male | Stomach Neoplasms - pathology | Tomography, X-Ray Computed | Colectomy | Chemoradiotherapy, Adjuvant | Fluorouracil - therapeutic use | Neoplasms, Multiple Primary - therapy | Gastrectomy - methods | Rectal Neoplasms - genetics | Leucovorin - therapeutic use | Rectal Neoplasms - pathology | Adenocarcinoma, Mucinous - therapy | Neoplasms, Multiple Primary - diagnosis | Colonic Neoplasms - therapy | Stomach Neoplasms - genetics | Neoplasms, Multiple Primary - genetics | Stomach Neoplasms - diagnosis | Jejunal Neoplasms - therapy | Biomarkers, Tumor - analysis | Stomach Neoplasms - therapy | Endoscopy, Gastrointestinal | Neoplasms, Multiple Primary - pathology | Rectal Neoplasms - therapy | Jejunal Neoplasms - diagnosis | Positron Emission Tomography Computed Tomography | Adenocarcinoma, Mucinous - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gastrointestinal Hemorrhage - etiology | Cancer Pain - etiology | Colonic Neoplasms - pathology | Adenocarcinoma, Mucinous - genetics | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Jejunal Neoplasms - pathology | Case Report
Journal Article
EMBO molecular medicine, ISSN 1757-4684, 2014, Volume 6, Issue 10, pp. 1279 - 1293
Epithelial‐mesenchymal transition (EMT) is a reversible and dynamic process hypothesized to be co‐opted by carcinoma during invasion and metastasis. Yet, there... 
drug response | microarray | gene expression signature | epithelial‐mesenchymal transition | prognosis | Drug response | Epithelial-mesenchymal transition | Prognosis | Microarray | Gene expression signature | MOLECULAR SUBTYPES | MEDICINE, RESEARCH & EXPERIMENTAL | GENE-EXPRESSION SIGNATURE | STEM-CELLS | GENOMIC ANALYSES | OVARIAN-CANCER | NEGATIVE BREAST-CANCER | CLINICAL-RELEVANCE | MICRORNA CONTROL | CLAUDIN-LOW | epithelial-mesenchymal transition | SIGNATURE PREDICTS RESISTANCE | Lung Neoplasms - drug therapy | Oligonucleotide Array Sequence Analysis | Colorectal Neoplasms - genetics | Humans | Epithelial-Mesenchymal Transition - drug effects | Antineoplastic Agents - therapeutic use | Epithelial-Mesenchymal Transition - genetics | Ovarian Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | Female | Gene Expression Regulation, Neoplastic - drug effects | Ovarian Neoplasms - drug therapy | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | Treatment Outcome | Transcriptome - drug effects | Transcriptome - genetics | Stomach Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Disease-Free Survival | Breast Neoplasms - genetics | Cell Line, Tumor | Cancer patients | Chemotherapy | Patient outcomes | Stem cells | Development and progression | Drug therapy | Gene expression | Ovarian cancer | Cancer | Mesenchyme | Colorectal carcinoma | Genomes | Breast cancer | Metastasis | Kinases | Cancer therapies | Metastases | Breast carcinoma | Genotype & phenotype | Paclitaxel | Breast | Software | Tumors
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 68, Issue 2, pp. 581 - 591
Purpose: To analyze the interfractional variations in patient setup and anatomic changes at seven anatomic sites observed in image-guided radiotherapy... 
Radiology | Hematology, Oncology and Palliative Medicine | Organ motion | Image-guided radiotherapy | Helical tomotherapy | Margin | Adaptive radiotherapy | margin | ONLINE CORRECTION | INTENSITY-MODULATED RADIOTHERAPY | adaptive radiotherapy | helical tomotherapy | organ motion | LUNG-CANCER | DOSE-ESCALATION | EXTERNAL-BEAM RADIOTHERAPY | ADAPTIVE RADIATION-THERAPY | ONCOLOGY | CONFORMAL RADIOTHERAPY | PROSTATE-CANCER | TREATMENT MARGINS | image-guided radiotherapy | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Skin Neoplasms - radiotherapy | Uterine Neoplasms - diagnostic imaging | Brain Neoplasms - diagnostic imaging | Humans | Tomography, Spiral Computed - methods | Male | Thoracic Neoplasms - diagnostic imaging | Pelvic Neoplasms - radiotherapy | Thoracic Neoplasms - radiotherapy | Dose Fractionation | Female | Neoplasms - radiotherapy | Uterine Neoplasms - radiotherapy | Brain Neoplasms - radiotherapy | Stomach Neoplasms - radiotherapy | Skin Neoplasms - diagnostic imaging | Movement | Stomach Neoplasms - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Pancreatic Neoplasms - radiotherapy | Neoplasms - diagnostic imaging | Pelvic Neoplasms - diagnostic imaging | Head and Neck Neoplasms - radiotherapy | Scalp | Extremities - diagnostic imaging | Neoplasms - pathology | Pancreatic Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated | Medicine, Experimental | Medical research | CT imaging | HEAD | PATIENTS | ERRORS | UTERUS | PANCREAS | SKULL | COMPUTERIZED TOMOGRAPHY | CHEST | KIDNEYS | ABDOMEN | IMAGES | SARCOMAS | RADIOLOGY AND NUCLEAR MEDICINE | PELVIS | NECK | RADIOTHERAPY | BRAIN
Journal Article
The Oncologist, ISSN 1083-7159, 05/2011, Volume 16, Issue 5, pp. 602 - 613
Journal Article
Seminars in Oncology, ISSN 0093-7754, 12/2013, Volume 40, Issue 6, pp. 676 - 689
Eighteen percent of incident malignancies in the United States are a second (or subsequent) cancer. Second primary neoplasms... 
LONG-TERM SURVIVORS | PRIMARY THYROID-CANCER | LI-FRAUMENI-SYNDROME | ONCOLOGY | EXTENDED FOLLOW-UP | ACUTE LYMPHOBLASTIC-LEUKEMIA | SQUAMOUS-CELL CARCINOMA | NON-HODGKINS-LYMPHOMA | UPPER AERODIGESTIVE TRACT | CORONARY-HEART-DISEASE | CHILDHOOD-CANCER SURVIVOR | Smoking - adverse effects | United States | Humans | Neoplasms, Radiation-Induced - etiology | Thyroid Neoplasms - epidemiology | Breast Neoplasms - etiology | Male | Radiotherapy - adverse effects | Gene-Environment Interaction | Neoplastic Syndromes, Hereditary | Hodgkin Disease - radiotherapy | Colorectal Neoplasms - etiology | Squamous Cell Carcinoma of Head and Neck | Skin Neoplasms - prevention & control | Head and Neck Neoplasms - epidemiology | Female | Neoplasms, Radiation-Induced - prevention & control | Stomach Neoplasms - epidemiology | Stomach Neoplasms - etiology | Thyroid Neoplasms - prevention & control | Breast Neoplasms - epidemiology | Colorectal Neoplasms - epidemiology | Genetic Predisposition to Disease | Head and Neck Neoplasms - prevention & control | Risk Assessment | Risk Reduction Behavior | Carcinoma, Squamous Cell - epidemiology | Risk Factors | Thyroid Neoplasms - etiology | Colorectal Neoplasms - prevention & control | Carcinoma, Squamous Cell - prevention & control | Skin Neoplasms - epidemiology | Breast Neoplasms - prevention & control | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Neoplasms, Second Primary - prevention & control | Carcinoma, Squamous Cell - etiology | Head and Neck Neoplasms - etiology | Stomach Neoplasms - prevention & control | Skin Neoplasms - etiology | Antineoplastic Agents, Alkylating - adverse effects | Neoplasms, Radiation-Induced - epidemiology
Journal Article
Journal Article
World Journal of Surgical Oncology, ISSN 1477-7819, 08/2017, Volume 15, Issue 1, p. 160
Background: Neurofibromatosis type 1 (NF1) is an autosomally dominant inherited disorder characterized by multiple pigmented skin spots (cafE-au-lait spots)... 
SURGERY | NF1 | RECKLINGHAUSENS DISEASE | GENE | ONCOLOGY | MANIFESTATIONS | Adenocarcinoma - pathology | Jejunum - pathology | Humans | Tomography, X-Ray Computed - methods | Neurofibromatosis 1 - therapy | Duodenal Neoplasms - complications | Neurofibroma - pathology | Neoplasms, Multiple Primary - therapy | Laparoscopy - methods | Chemotherapy, Adjuvant - adverse effects | Contrast Media - administration & dosage | Skin Neoplasms - diagnosis | Endoscopy, Gastrointestinal - methods | Occult Blood | Rectal Neoplasms - pathology | Duodenum - diagnostic imaging | Duodenal Neoplasms - pathology | Digestive System Surgical Procedures - methods | Skin Neoplasms - therapy | Rectal Neoplasms - complications | Neurofibromatosis 1 - diagnosis | Lymphatic Metastasis | Withholding Treatment | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Adenocarcinoma - diagnosis | Gastrointestinal Stromal Tumors - therapy | Adenocarcinoma - therapy | Neurofibromatosis 1 - complications | Neoplasms, Multiple Primary - complications | Intestinal Neoplasms - complications | Rectal Neoplasms - diagnosis | Prognosis | Intestine, Small - pathology | Neurofibroma - complications | Diarrhea - chemically induced | Gastrointestinal Stromal Tumors - diagnosis | Gastrointestinal Stromal Tumors - pathology | Female | Intestinal Neoplasms - diagnosis | Neurofibroma - diagnosis | Neoplasms, Multiple Primary - diagnosis | Skin Neoplasms - pathology | Jejunum - surgery | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Neoplasms, Multiple Primary - pathology | Rectal Neoplasms - therapy | Adenocarcinoma - complications | Skin Neoplasms - complications | Neurofibroma - therapy | Neurofibromatosis 1 - pathology | Duodenum - surgery | Intestine, Small - surgery | Biopsy | Chemotherapy, Adjuvant - methods | Duodenum - pathology | Intestine, Small - diagnostic imaging | Gastrointestinal Stromal Tumors - complications | Aged | Neoplasm Staging | Jejunum - diagnostic imaging | Case studies | Complications and side effects | Care and treatment | Neurofibromatosis | Colorectal cancer | Diagnosis | Stomach cancer | Risk factors | Adenocarcinoma | Colorectal carcinoma | Nervous system | Small intestine | Lymph nodes | Metastases | Proteins | Endoscopes | Jejunum | Colonoscopy | Surgery | Spots | Population | Endoscopy | Colon | Digestive tract | CD34 antigen | Antigens | Lymphatic system | Duodenum | Histology | Laparoscopy | Recklinghausen's disease | Patients | Hereditary diseases | Abdomen | Nodules | Ostomy | Rectum | Skin | Mutation | Cancer | Tumors
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 1, pp. 130 - 137
...) patients treated with curative-intent radiation therapy (RT) alone. Patients and Methods We reviewed the charts of 490 consecutive patients with stage IE or IIE MZL referred between 1992 and 2012 to our institution... 
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | MULTICENTER | ONCOLOGY | TISSUE LYMPHOMA | RADIOTHERAPY | MALT LYMPHOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | STOMACH | Recurrence | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Age Factors | Follow-Up Studies | Skin Neoplasms - radiotherapy | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Cause of Death | Lymphoma, B-Cell, Marginal Zone - mortality | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Neoplasms, Radiation-Induced | Orbital Neoplasms - radiotherapy | Skin Neoplasms - pathology | Stomach Neoplasms - radiotherapy | Orbital Neoplasms - pathology | Treatment Outcome | Head and Neck Neoplasms - pathology | Neoplasms, Second Primary - etiology | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Breast Neoplasms - radiotherapy | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Head and Neck Neoplasms - mortality | Orbital Neoplasms - mortality | Stomach Neoplasms - mortality | Antimitotic agents | Sects | Care and treatment | Radiation | Radiotherapy | Antineoplastic agents | Cancer | Tumors | REVIEWS | HEAD | PATIENTS | MAMMARY GLANDS | THYROID | DEATH | RADIATION DOSES | SYMPTOMS | PATHOLOGY | LYMPHOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | SKIN | HAZARDS
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2015, Volume 65, Issue 2, pp. 87 - 108
Journal Article